HEADER IMMUNOGLOBULIN 13-JUN-83 2RHE TITLE STRUCTURE OF A NOVEL BENCE-JONES PROTEIN (RHE) FRAGMENT AT 1.6 TITLE 2 ANGSTROMS RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: BENCE-JONES PROTEIN RHE (LIGHT CHAIN); COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: URINE KEYWDS IMMUNOGLOBULIN EXPDTA X-RAY DIFFRACTION AUTHOR W.FUREYJUNIOR,B.C.WANG,C.S.YOO,M.SAX REVDAT 7 29-NOV-17 2RHE 1 HELIX REVDAT 6 25-AUG-09 2RHE 1 SOURCE REVDAT 5 24-FEB-09 2RHE 1 VERSN REVDAT 4 01-APR-03 2RHE 1 JRNL REVDAT 3 09-OCT-88 2RHE 1 FORMUL REVDAT 2 30-SEP-83 2RHE 1 REVDAT REVDAT 1 15-SEP-83 2RHE 0 SPRSDE 15-SEP-83 2RHE 1RHE JRNL AUTH W.FUREY JR.,B.C.WANG,C.S.YOO,M.SAX JRNL TITL STRUCTURE OF A NOVEL BENCE-JONES PROTEIN (RHE) FRAGMENT AT JRNL TITL 2 1.6 A RESOLUTION. JRNL REF J.MOL.BIOL. V. 167 661 1983 JRNL REFN ISSN 0022-2836 JRNL PMID 6876161 JRNL DOI 10.1016/S0022-2836(83)80104-1 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH W.FUREYJUNIOR,B.C.WANG,C.S.YOO,M.SAX REMARK 1 TITL PHASE EXTENSION AND REFINEMENT OF BENCE-JONES PROTEIN RHE REMARK 1 TITL 2 (1.9 ANGSTROMS) REMARK 1 REF ACTA CRYSTALLOGR.,SECT.A V. 35 810 1979 REMARK 1 REFN ISSN 0108-7673 REMARK 1 REFERENCE 2 REMARK 1 AUTH B.-C.WANG,C.S.YOO,M.SAX REMARK 1 TITL CRYSTAL STRUCTURE OF BENCE JONES PROTEIN RHE (3 ANGSTROMS) REMARK 1 TITL 2 AND ITS UNIQUE DOMAIN-DOMAIN ASSOCIATION REMARK 1 REF J.MOL.BIOL. V. 129 657 1979 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 3 REMARK 1 AUTH B.-C.WANG,M.SAX REMARK 1 TITL STRUCTURE OF A DIMERIC FRAGMENT RELATED TO THE LAMBDA-TYPE REMARK 1 TITL 2 BENCE-JONES PROTEIN. A PRELIMINARY STUDY REMARK 1 REF J.MOL.BIOL. V. 87 505 1974 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PROLSQ REMARK 3 AUTHORS : KONNERT,HENDRICKSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 12763 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.149 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 833 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 186 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 ALTHOUGH THE CHEMICAL EVIDENCE INDICATES THAT RESIDUE 1 IS REMARK 3 PCA (PYROLLIDONE CARBOXYLIC ACID) WHICH IS A CYCLIZED REMARK 3 GLUTAMIC ACID, THE COORDINATES GIVEN BELOW ARE THOSE OF THE REMARK 3 UNCYCLIZED GLUTAMIC ACID (GLU) WHICH WAS USED IN THE REMARK 3 REFINEMENT PROCESS. ALMOST NO ELECTRON DENSITY WAS REMARK 3 OBSERVED FOR THIS RESIDUE IN THE CRYSTALLOGRAPHIC STUDY REMARK 3 INDICATING THAT THIS RESIDUE IS BADLY DISORDERED AND DOES REMARK 3 NOT PACK WELL INTO THE LATTICE. THEREFORE NO ATTEMPT WAS REMARK 3 MADE TO FIT A PCA GROUP TO THE DATA. THIS DISCREPANCY HAS REMARK 3 NO EFFECT ON THE REMAINDER OF THE STRUCTURE. REMARK 3 REMARK 3 THE SOLVENT STRUCTURE HAS BEEN DETERMINED TO THE EXTENT REMARK 3 THAT 35 PER CENT OF ALL WATERS WERE FOUND AND REFINED. THE REMARK 3 FIRST 102 WATER SITES ARE FULLY OCCUPIED AND ARE BELIEVED REMARK 3 TO BE ACCURATELY PLACED. OCCUPANCIES WERE REFINED FOR THE REMARK 3 REMAINING WATER SITES, AND THEIR POSITIONS ARE LIKELY TO BE REMARK 3 KNOWN WITH LESS ACCURACY. ALL WATER SITES INCLUDED IN THIS REMARK 3 ENTRY ARE CHEMICALLY SENSIBLE IN THAT HYDROGEN BONDS ARE REMARK 3 FORMED TO SUITABLE DONORS OR ACCEPTORS AND NO BAD PACKING REMARK 3 CONTACTS ARE FORMED. WATERS 115, 117, 118, 121 AND 123 REMARK 3 ARE PARTICULARLY SIGNIFICANT AND APPEAR TO BE INTEGRAL REMARK 3 PARTS OF THE PROTEIN STRUCTURE. REMARK 4 REMARK 4 2RHE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000178559. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.57 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 27.31500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 26.11000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.31500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 26.11000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THIS MOLECULE EXISTS AS A DIMER BOTH IN SOLUTION AND IN THE REMARK 300 CRYSTALS, BUT THE TWO-FOLD AXIS OF DIMERIZATION IS ALIGNED REMARK 300 WITH THE CRYSTALLOGRAPHIC Z-AXIS. THUS THE ASYMMETRIC UNIT REMARK 300 CONTAINS ONLY A MONOMER. TO GENERATE THE INTACT DIMER, REMARK 300 APPLY THE OPERATION -X, -Y, Z TO THE COORDINATES BELOW. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 258 O HOH A 259 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 SER A 9 CA SER A 9 CB 0.115 REMARK 500 SER A 57 CA SER A 57 CB 0.117 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 SER A 2 C - N - CA ANGL. DEV. = 15.6 DEGREES REMARK 500 SER A 2 N - CA - CB ANGL. DEV. = 14.3 DEGREES REMARK 500 SER A 2 CA - CB - OG ANGL. DEV. = 16.9 DEGREES REMARK 500 SER A 9 CA - CB - OG ANGL. DEV. = -24.6 DEGREES REMARK 500 ALA A 10 N - CA - CB ANGL. DEV. = 9.6 DEGREES REMARK 500 ILE A 35 CA - CB - CG2 ANGL. DEV. = 17.0 DEGREES REMARK 500 TYR A 37 CB - CG - CD2 ANGL. DEV. = -3.7 DEGREES REMARK 500 LYS A 46 CB - CG - CD ANGL. DEV. = 29.6 DEGREES REMARK 500 ASP A 53 CB - CG - OD1 ANGL. DEV. = 9.2 DEGREES REMARK 500 SER A 57 N - CA - CB ANGL. DEV. = 15.7 DEGREES REMARK 500 SER A 57 CA - CB - OG ANGL. DEV. = -22.3 DEGREES REMARK 500 ASP A 61 CB - CG - OD2 ANGL. DEV. = -12.2 DEGREES REMARK 500 ARG A 62 CD - NE - CZ ANGL. DEV. = 16.2 DEGREES REMARK 500 SER A 64 N - CA - CB ANGL. DEV. = 9.4 DEGREES REMARK 500 LYS A 67 CG - CD - CE ANGL. DEV. = 23.6 DEGREES REMARK 500 GLY A 69 CA - C - O ANGL. DEV. = -13.8 DEGREES REMARK 500 SER A 73 N - CA - CB ANGL. DEV. = -10.3 DEGREES REMARK 500 GLU A 80 OE1 - CD - OE2 ANGL. DEV. = 7.9 DEGREES REMARK 500 ASP A 86 CB - CG - OD2 ANGL. DEV. = -10.5 DEGREES REMARK 500 TYR A 88 CB - CG - CD1 ANGL. DEV. = -3.7 DEGREES REMARK 500 TYR A 88 CG - CD1 - CE1 ANGL. DEV. = -5.1 DEGREES REMARK 500 ASP A 94 OD1 - CG - OD2 ANGL. DEV. = -11.8 DEGREES REMARK 500 ASP A 94 CB - CG - OD1 ANGL. DEV. = 7.4 DEGREES REMARK 500 ASP A 97 CB - CG - OD1 ANGL. DEV. = -12.2 DEGREES REMARK 500 GLU A 98 CA - CB - CG ANGL. DEV. = 45.9 DEGREES REMARK 500 PHE A 101 CB - CG - CD2 ANGL. DEV. = -4.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 2 -14.59 68.52 REMARK 500 ASP A 28 -94.33 -113.75 REMARK 500 ASN A 52 -45.67 70.94 REMARK 500 ASP A 53 11.48 -143.68 REMARK 500 REMARK 500 REMARK: NULL DBREF 2RHE A 2 114 PIR S25752 S25752 19 131 SEQADV 2RHE THR A 23 PIR S25752 SER 40 CONFLICT SEQADV 2RHE ALA A 26 PIR S25752 SER 43 CONFLICT SEQADV 2RHE THR A 27 PIR S25752 SER 44 CONFLICT SEQADV 2RHE ASP A 28 PIR S25752 ASN 45 CONFLICT SEQADV 2RHE SER A 33 PIR S25752 THR 50 CONFLICT SEQADV 2RHE ILE A 35 PIR S25752 ASN 52 CONFLICT SEQADV 2RHE VAL A 40 PIR S25752 LEU 57 CONFLICT SEQADV 2RHE LYS A 43 PIR S25752 THR 60 CONFLICT SEQADV 2RHE TYR A 51 PIR S25752 ARG 68 CONFLICT SEQADV 2RHE ASP A 53 PIR S25752 ASN 70 CONFLICT SEQADV 2RHE LEU A 54 PIR S25752 GLN 71 CONFLICT SEQADV 2RHE LEU A 55 PIR S25752 ARG 72 CONFLICT SEQADV 2RHE SER A 60 PIR S25752 PRO 77 CONFLICT SEQADV 2RHE ALA A 65 PIR S25752 GLY 82 CONFLICT SEQADV 2RHE GLU A 80 PIR S25752 GLN 97 CONFLICT SEQADV 2RHE ASN A 93 PIR S25752 ASP 110 CONFLICT SEQADV 2RHE ASP A 97 PIR S25752 ASN 114 CONFLICT SEQADV 2RHE GLU A 98 PIR S25752 GLY 115 CONFLICT SEQADV 2RHE PRO A 99 PIR S25752 VAL 116 CONFLICT SEQADV 2RHE GLY A 100 PIR S25752 VAL 117 CONFLICT SEQRES 1 A 114 GLU SER VAL LEU THR GLN PRO PRO SER ALA SER GLY THR SEQRES 2 A 114 PRO GLY GLN ARG VAL THR ILE SER CYS THR GLY SER ALA SEQRES 3 A 114 THR ASP ILE GLY SER ASN SER VAL ILE TRP TYR GLN GLN SEQRES 4 A 114 VAL PRO GLY LYS ALA PRO LYS LEU LEU ILE TYR TYR ASN SEQRES 5 A 114 ASP LEU LEU PRO SER GLY VAL SER ASP ARG PHE SER ALA SEQRES 6 A 114 SER LYS SER GLY THR SER ALA SER LEU ALA ILE SER GLY SEQRES 7 A 114 LEU GLU SER GLU ASP GLU ALA ASP TYR TYR CYS ALA ALA SEQRES 8 A 114 TRP ASN ASP SER LEU ASP GLU PRO GLY PHE GLY GLY GLY SEQRES 9 A 114 THR LYS LEU THR VAL LEU GLY GLN PRO LYS FORMUL 2 HOH *186(H2 O) HELIX 1 A SER A 25 ASN A 32 1NON-STANDARD TORSION ANGLES 8 SHEET 1 A 3 GLY A 15 GLY A 24 0 SHEET 2 A 3 THR A 70 LEU A 79 -1 O THR A 70 N GLY A 24 SHEET 3 A 3 ARG A 62 SER A 68 -1 O ARG A 62 N SER A 77 SHEET 1 B 4 LYS A 46 ILE A 49 0 SHEET 2 B 4 ILE A 35 GLN A 39 -1 N TRP A 36 O ILE A 49 SHEET 3 B 4 ALA A 85 ALA A 91 -1 O ASP A 86 N GLN A 39 SHEET 4 B 4 GLY A 100 LEU A 107 -1 N GLY A 100 O ALA A 91 SSBOND 1 CYS A 22 CYS A 89 1555 1555 2.03 CRYST1 54.630 52.220 42.620 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018305 0.000000 0.000000 0.00000 SCALE2 0.000000 0.019150 0.000000 0.00000 SCALE3 0.000000 0.000000 0.023463 0.00000